M. Hropot

1.1k total citations
35 papers, 811 citations indexed

About

M. Hropot is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, M. Hropot has authored 35 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in M. Hropot's work include Ion Transport and Channel Regulation (8 papers), Ion channel regulation and function (7 papers) and Neuroscience and Neuropharmacology Research (4 papers). M. Hropot is often cited by papers focused on Ion Transport and Channel Regulation (8 papers), Ion channel regulation and function (7 papers) and Neuroscience and Neuropharmacology Research (4 papers). M. Hropot collaborates with scholars based in Germany, United States and Israel. M. Hropot's co-authors include Gerhard Giebisch, Hans‐Jochen Lang, Nicole Fowler, Bertil Karlmark, Kerstin Richter, Gerhard Burckhardt, H W Jansen, Wolfgang Krick, Volker Vallon and Peter S. Aronson and has published in prestigious journals such as Kidney International, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M. Hropot

30 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Hropot Germany 13 527 172 167 130 111 35 811
Monique C. Churchill United States 19 363 0.7× 394 2.3× 132 0.8× 171 1.3× 156 1.4× 56 947
F. Leviel France 20 668 1.3× 111 0.6× 306 1.8× 136 1.0× 279 2.5× 39 987
M. De Luise Australia 14 314 0.6× 146 0.8× 74 0.4× 192 1.5× 145 1.3× 23 895
H. Dahlheim Germany 15 242 0.5× 322 1.9× 75 0.4× 115 0.9× 122 1.1× 41 719
Michael Horster Germany 19 660 1.3× 68 0.4× 268 1.6× 80 0.6× 217 2.0× 39 1.1k
Yasuyoshi Yamaji Japan 18 622 1.2× 153 0.9× 100 0.6× 140 1.1× 169 1.5× 29 864
A. Gougoux Canada 14 342 0.6× 52 0.3× 106 0.6× 169 1.3× 249 2.2× 58 852
G. W. Boyd Australia 14 215 0.4× 295 1.7× 126 0.8× 62 0.5× 75 0.7× 36 799
Jon Norseth Norway 18 303 0.6× 171 1.0× 84 0.5× 161 1.2× 71 0.6× 35 763
Mariagnes Verosky United States 15 334 0.6× 150 0.9× 81 0.5× 220 1.7× 44 0.4× 51 777

Countries citing papers authored by M. Hropot

Since Specialization
Citations

This map shows the geographic impact of M. Hropot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hropot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hropot more than expected).

Fields of papers citing papers by M. Hropot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hropot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hropot. The network helps show where M. Hropot may publish in the future.

Co-authorship network of co-authors of M. Hropot

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hropot. A scholar is included among the top collaborators of M. Hropot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hropot. M. Hropot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hropot, M., et al.. (2003). Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 367(3). 312–317. 10 indexed citations
2.
Hropot, M., et al.. (2001). S3226, a novel NHE3 inhibitor, attenuates ischemia-induced acute renal failure in rats. Kidney International. 60(6). 2283–2289. 30 indexed citations
3.
Wang, Tong, M. Hropot, Peter S. Aronson, & Gerhard Giebisch. (2001). Role of NHE isoforms in mediating bicarbonate reabsorption along the nephron. American Journal of Physiology-Renal Physiology. 281(6). F1117–F1122. 77 indexed citations
4.
Jansen, H W, et al.. (1998). S3226, a novel inhibitor of Na + /H + exchanger subtype 3 in various cell types. Pflügers Archiv - European Journal of Physiology. 436(5). 797–800. 129 indexed citations
5.
Wirth, Klaus, Martin Bickel, M. Hropot, et al.. (1997). The bradykinin B2 receptor antagonist Icatibant (HOE 140) corrects avid Na+ retention in rats with CCl4-induced liver cirrhosis: possible role of enhanced microvascular leakage. European Journal of Pharmacology. 337(1). 45–53. 18 indexed citations
6.
Kunick, Conrad, Andreas Link, & M. Hropot. (1996). Synthesis and in vivo testing of a potential aquaretic agent.. PubMed. 51(8). 601–2. 1 indexed citations
7.
Lang, Hans‐Jochen, et al.. (1996). A Novel Screening Assay of the Na<sup>+</sup>-Dependent Cl<sup>-</sup>/HCO<sup>-</sup><sub>3</sub> Exchanger (NCBE) and Its Inhibitors. Cellular Physiology and Biochemistry. 6(1-2). 39–49. 4 indexed citations
8.
Ecke, D., Markus Bleich, E. Lohrmann, et al.. (1995). A Chromanol Type of K<sup>+</sup> Channel Blocker Inhibits Forskolin- but Not Carbachol-Mediated Cl- Secretion in Rat and Rabbit Colon. Cellular Physiology and Biochemistry. 5(4). 204–210. 23 indexed citations
9.
Lohrmann, E., Roland Nitschke, Hans‐Jochen Lang, et al.. (1995). A new class of inhibitors of cAMP-mediated Cl? secretion in rabbit colon, acting by the reduction of cAMP-activated K+ conductance. Pflügers Archiv - European Journal of Physiology. 429(4). 517–530. 117 indexed citations
10.
Norris, David G., Thoralf Niendorf, Mathias Hoehn‐Berlage, et al.. (1994). Incidence of apparent restricted diffusion in three different models of cerebral infarction. Magnetic Resonance Imaging. 12(8). 1175–1182. 37 indexed citations
11.
Hropot, M., et al.. (1994). Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(6). 646–52. 32 indexed citations
12.
Hropot, M., et al.. (1994). Diminished Diuretic and Natriuretic Response to Furosemide in Potassium-Depleted Rats. Kidney & Blood Pressure Research. 17(1). 10–20. 5 indexed citations
13.
Hropot, M., et al.. (1992). Pharmacokinetic investigations of the α-human thrombin-hirudin complex in rhesus monkeys. Thrombosis Research. 66(2-3). 271–275. 3 indexed citations
14.
Hropot, M., et al.. (1991). Interference of heparin and analogues with hirudin in the chromogenic thrombin substrate assay. Thrombosis Research. 64(2). 285–290. 6 indexed citations
15.
Hropot, M., et al.. (1991). Degradation of rDNA hirudin and α-human thrombin hirudin complex in liver and kidney homogenates from rat. Thrombosis Research. 64(6). 763–767. 3 indexed citations
16.
Greger, R., Roland Nitschke, E. Lohrmann, et al.. (1991). Effects of arylaminobenzoate-type chloride channel blockers on equivalent short-circuit current in rabbit colon. Pflügers Archiv - European Journal of Physiology. 419(2). 190–196. 30 indexed citations
17.
Hropot, M., et al.. (1983). Enzymuria of the Rat: The Preparation of Urine for Enzyme Analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 21(12). 799–804. 5 indexed citations
18.
Hropot, M., et al.. (1980). Pharmacological Effects of 1,3,5-Triazines and Their Excretion Characteristics in the Rat. Advances in experimental medicine and biology. 122A. 269–276. 1 indexed citations
19.
Hropot, M., et al.. (1975). Proceedings: Micropuncture studies with neutral salts of so-called "high ceiling" diuretics.. PubMed. 287 Suppl. R56–R56. 1 indexed citations
20.
Gropper, Michael A., et al.. (1972). [Clinical aspects of acute bovine mastitis (mastitis acute gravis). 4. Clinical picture].. PubMed. 85(18). 344–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique C. Churchill Breakdown of academic impact, for papers by F. Leviel Breakdown of academic impact, for papers by M. De Luise Breakdown of academic impact, for papers by H. Dahlheim Breakdown of academic impact, for papers by Michael Horster Breakdown of academic impact, for papers by Yasuyoshi Yamaji Breakdown of academic impact, for papers by A. Gougoux Breakdown of academic impact, for papers by G. W. Boyd Breakdown of academic impact, for papers by Jon Norseth Breakdown of academic impact, for papers by Mariagnes Verosky
Rankless by CCL
2026